The Indiba Deep Beauty radiofrequency device will now be imported and distributed in the UK exclusively through Silver Street Associates (SSA).
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
Pharmaceutical company Allergan has announced the launch of Juvéderm VOLITE, the company’s first injectable treatment designed to improve skin quality.
Aesthetic practitioners were invited to The Lansdowne Club in Mayfair for the launch of the Regenyal injectable range on the evening of March 1.
Dermatological distribution company SkinMed has confirmed new training dates for its ‘Bespoke Chemical & Physical Remodelling Training’ and ‘Acne & Rosacea Training’ courses.
Product distributor, SkinMed has launched two new products designed for treating oily and problematic skin.
A study published in Dermatologic Surgery has indicated that patients with mild-to-moderate rosacea experienced improvement following fractional microneedling radiofrequency (FMR) treatment.
Pharmaceutical company Galderma invited guests to a celebratory breakfast in the Duncan Room at the Charlotte Street Hotel for the 20th anniversary of Restylane.
Aesthetic practitioners were invited to learn about the science behind the AlumierMD cosmeceutical range at a cocktail and canapé reception on September 13 in central London.